Chiesi Group Selects Salesforce Agentforce Life Sciences to Transform Customer Engagement
Chiesi Group deploys Salesforce Agentforce across life sciences customer engagement—not a pilot, full digital transformation.
Why it matters
Enterprise AI adoption in regulated industries is accelerating. Salesforce's vertical-specific agent offering (Life Sciences) signals a shift from horizontal AI tools to domain-optimized agent platforms as the competitive battleground.
The key facts
8 to knowChiesi Group (international biopharmaceutical) selects Salesforce Agentforce Life Sciences
Focus: AI-powered customer engagement, unified data integration
Vertical-specific agent platform deployment in regulated life sciences sector
Published April 20, 2026 (breaking/recent)
Chiesi Group (international biopharmaceutical leader) selected Salesforce Agentforce Life Sciences
Use case: AI-powered customer engagement, unified data, integration capabilities
Published April 20, 2026 — suggests recent/current deployment
Vertical-specific agent product (Life Sciences edition) indicates market segmentation strategy
Go to the source
Salesforce Newsroomsalesforce.com
Publisher excerpt: International biopharmaceutical leader accelerates digital transformation with AI-powered customer engagement, unified data, and next-generation integration capabilities